Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
- PMID: 2833705
- DOI: 10.1038/332644a0
Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
Abstract
The generation of second messengers from the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdInsP2) by phosphoinositidase C has been implicated in the mediation of cellular responses to a variety of growth factors and oncogene products. The first step in the production of PtdInsP2 from phosphatidylinositol (PtdIns) is catalysed by PtdIns kinase. A PtdIns kinase activity has been found to associate specifically with several oncogene products, as well as with the platelet-derived growth factor (PDGF) receptor. We have previously identified two biochemically distinct PtdIns kinases in fibroblasts, and have found that only one of these, designated type I, specifically associates with activated tyrosine kinases. We have now characterized the site on the inositol ring phosphorylated by type I PtdIns kinase, and find that this kinase specifically phosphorylates the D-3 ring position to generate a novel phospholipid, phosphatidylinositol-3-phosphate (PtdIns(3)P). In contrast, the main PtdIns kinase in fibroblasts, designated type II, specifically phosphorylates the D-4 position to produce phosphatidylinositol-4-phosphate (PtdIns(4)P), previously considered to be the only form of PtdInsP. We have also tentatively identified PtdIns(3)P as a minor component of total PtdInsP in intact fibroblasts. We propose that type I PtdIns kinase is responsible for the generation of PtdIns(3)P in intact cells, and that this novel phosphoinositide could be important in the transduction of mitogenic and oncogenic signals.
Similar articles
-
The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase.Nature. 1989 Dec 7;342(6250):699-702. doi: 10.1038/342699a0. Nature. 1989. PMID: 2556641
-
A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.Nature. 1997 Nov 13;390(6656):192-6. doi: 10.1038/36621. Nature. 1997. PMID: 9367159
-
Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.Endocrinology. 1988 Dec;123(6):2793-9. doi: 10.1210/endo-123-6-2793. Endocrinology. 1988. PMID: 2904359
-
Phosphoinositide 3-kinase: a new effector in signal transduction?Cell Signal. 1991;3(6):501-13. doi: 10.1016/0898-6568(91)90027-r. Cell Signal. 1991. PMID: 1664737 Review.
-
Type II phosphatidylinositol 4-kinase(s) in cell signaling cascades.Indian J Biochem Biophys. 2007 Oct;44(5):289-94. Indian J Biochem Biophys. 2007. PMID: 18341203 Review.
Cited by
-
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.Oncoimmunology. 2024 Jul 18;13(1):2379062. doi: 10.1080/2162402X.2024.2379062. eCollection 2024. Oncoimmunology. 2024. PMID: 39036370 Free PMC article. Review.
-
Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer.Cancer Chemother Pharmacol. 2024 Sep;94(3):421-436. doi: 10.1007/s00280-024-04690-4. Epub 2024 Jun 27. Cancer Chemother Pharmacol. 2024. PMID: 38937298
-
PI3Kγδ inhibition suppresses key disease features in a rat model of asthma.Respir Res. 2024 Apr 23;25(1):175. doi: 10.1186/s12931-024-02814-1. Respir Res. 2024. PMID: 38654248 Free PMC article.
-
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.Cancer Discov. 2024 Feb 8;14(2):240-257. doi: 10.1158/2159-8290.CD-23-0944. Cancer Discov. 2024. PMID: 37916956 Free PMC article.
-
Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells.Biochem Biophys Res Commun. 2023 Oct 30;679:116-121. doi: 10.1016/j.bbrc.2023.08.050. Epub 2023 Aug 26. Biochem Biophys Res Commun. 2023. PMID: 37683456 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources